BioNTech's Q2 revenue plunges 59.5%, loss doubles, 2026 guidance cut, and CEO Sahin exits as cash pile cushions the transition. BioNTech's Transition Math: How Long Can 16.6 Billion Euros Bridge the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results